GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ashland Inc (NYSE:ASH) » Definitions » Sloan Ratio %

Ashland (Ashland) Sloan Ratio %

: -3.78% (As of Dec. 2023)
View and export this data going back to 1950. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Ashland's Sloan Ratio for the quarter that ended in Dec. 2023 was -3.78%.

As of Dec. 2023, Ashland has a Sloan Ratio of -3.78%, indicating the company is in the safe zone and there is no funny business with accruals.


Ashland Sloan Ratio % Historical Data

The historical data trend for Ashland's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ashland Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sloan Ratio %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.07 -10.46 0.62 -6.70 0.74

Ashland Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.37 8.28 2.22 0.72 -3.78

Competitive Comparison

For the Specialty Chemicals subindustry, Ashland's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ashland Sloan Ratio % Distribution

For the Chemicals industry and Basic Materials sector, Ashland's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Ashland's Sloan Ratio % falls into.



Ashland Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Ashland's Sloan Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (A: Sep. 2023 )-Cash Flow from Operations (A: Sep. 2023 )
-Cash Flow from Investing (A: Sep. 2023 ))/Total Assets (A: Sep. 2023 )
=(178-243
--109)/5939
=0.74%

Ashland's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(163-493
--108)/5866
=-3.78%

Ashland's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 91 (Mar. 2023 ) + 50 (Jun. 2023 ) + -4 (Sep. 2023 ) + 26 (Dec. 2023 ) = $163 Mil.
Ashland's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 43 (Mar. 2023 ) + 140 (Jun. 2023 ) + 123 (Sep. 2023 ) + 187 (Dec. 2023 ) = $493 Mil.
Ashland's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -18 (Mar. 2023 ) + -12 (Jun. 2023 ) + -52 (Sep. 2023 ) + -26 (Dec. 2023 ) = $-108 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ashland  (NYSE:ASH) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Ashland has a Sloan Ratio of -3.78%, indicating the company is in the safe zone and there is no funny business with accruals.


Ashland Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Ashland's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ashland (Ashland) Business Description

Traded in Other Exchanges
Address
8145 Blazer Drive, Wilmington, DE, USA, 19808
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.
Executives
Eric N Boni officer: Principal Accounting Officer 8145 BLAZER DRIVE, WILMINGTON DE 19808
J Kevin Willis officer: Chief Financial Officer 50 E RIVERCENTER BLVD, COVINGTON KY 41011
James P. Minicucci officer: SVP Strategy, M&A & Portfolio 5474 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Karl R. Bostaph officer: SVP Operations 5474 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Robin E. Lampkin officer: SVP, Gen. Counsel & Secretary 5475 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Sergio Pedreiro director 2 PARK AVENUE, NEW YORK NY 10016
Eileen Drury officer: SVP and Chief Human Resources 8145 BLAZER DRIVE, WILMINGTON DE 19808
Ricky C Sandler director, other: See Remarks 65 EAST 55TH STREET, 25TH FLOOR, NEW YORK NY 10022
Steven D Bishop director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Suzan F. Harrison director 77 WEST WACKER DRIVE, SUITE 4600, CHICAGO IL 60601
Guillermo Novo director, officer: Chairman and CEO AIR PRODUCTS AND CHEMICALS, INC., 7201 HAMILTON BOULEVARD, ALLENTOWN PA 18195
Winkler Von Mohrenfels Petra Yvonne officer: Sr. VP, GC and Secretary 8145 BLAZER DRIVE, WILMINGTON DE 19808
Min Chong officer: Sr VP & Gen Mgr, Spc Additives 8145 BLAZER DRIVE, WILMINGTON DE 19808
Osama M Musa officer: Sr. Vice President ASHLAND GLOBAL HOLDINGS INC, 1005 ROUTE 202/206, BRIDGEWATER NJ 08807
Swaminathan Ashok Kalyana officer: Sr VP & Gen Mgr, Life Sciences 8145 BLAZER DRIVE, WILMINGTON DE 19808